Brf Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 09-12-2024
- Company Age 25 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.97 Cr
as on 09-12-2024
- Revenue -29.05%
(FY 2020)
- Profit 371.42%
(FY 2020)
- Ebitda 56.58%
(FY 2020)
- Net Worth 10.14%
(FY 2020)
- Total Assets -31.47%
(FY 2020)
About Brf Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.97 Cr.
Latha Tamil and Chidambaram Tamil serve as directors at the Company.
- CIN/LLPIN
U51109TN1999PTC043770
- Company No.
043770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Brf Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chidambaram Tamil  | Managing Director | 16-Dec-1999 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Latha Tamil | Director | 16-Dec-1999 | Current |
Financial Performance of Brf Lifescience.
Brf Lifescience Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 29.05% decrease. The company also saw a substantial improvement in profitability, with a 371.42% increase in profit. The company's net worth Soared by an impressive increase of 10.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brf Lifescience?
In 2019, Brf Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tla Research Laboratories Private LimitedActive 4 years 5 monthsLatha Tamil and Chidambaram Tamil are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 27 Jun 2013 | ₹2.44 M | Open |
Others Creation Date: 20 Oct 2012 | ₹3.72 Cr | Open |
How Many Employees Work at Brf Lifescience?
Unlock and access historical data on people associated with Brf Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brf Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brf Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
